Supernus Pharmaceuticals, Inc. (SUPN) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 66.52M | 19.86M | -61.66M | 58.53M | 30.6M | 44.41M | 53.52M | 35.62M | 38.4M | 44.96M | 35.88M | -18.87M | 49.13M | 27.56M | 13.84M | 71.12M | 4.3M | 48.76M | -4.11M | 46.27M |
| Operating CF Margin % | 32.03% | 9.39% | -32.1% | 35.38% | 20.42% | 25.5% | 30.46% | 21.16% | 26.73% | 27.36% | 23.31% | -13.92% | 31.95% | 16.47% | 7.8% | 41.82% | 2.82% | 30.66% | -2.77% | 32.74% |
| Operating CF Growth % | 117.41% | -55.27% | -215.22% | 64.31% | -20.32% | -1.23% | 49.18% | 288.75% | -21.83% | 63.1% | 159.19% | -126.54% | 1041.93% | -43.47% | 436.76% | 53.69% | -88.12% | 52.7% | -173.41% | -49.68% |
| Net Income | -2.29M | -38.55M | -45.12M | 22.5M | -11.83M | 15.33M | 38.5M | 19.92M | 124K | 1.18M | -15.98M | -831K | 16.95M | 25.48M | 1.75M | 7.87M | 25.62M | 2.44M | 21.56M | 23.73M |
| Depreciation & Amortization | 25.94M | 92.17M | 24.81M | 21.36M | 20.38M | 18.84M | 20.09M | 20.72M | 20.75M | 21.68M | 21.86M | 20.73M | 20.6M | 20.85M | 21.77M | 21.56M | 21.36M | 12.71M | 6.67M | 6.62M |
| Stock-Based Compensation | 8.48M | 33.05M | 7.83M | 7.51M | 8.07M | 7.63M | 7.67M | 6.55M | 5.9M | 6.45M | 7.92M | 6.09M | 6.31M | 4.26M | 4.99M | 4.3M | 4.03M | 4.04M | 4.03M | 5.48M |
| Deferred Taxes | 5.92M | 5.21M | -2.65M | -7.16M | -3.99M | -72K | -6.47M | -8.12M | -5.48M | -10.46M | -9.27M | -5.55M | -435K | -7.76M | -2.51M | -3.05M | -13.01M | -4.51M | 1.57M | 519K |
| Other Non-Cash Items | 28.48M | -20.66M | 2.67M | 2.84M | 4.06M | 7.8M | 1.61M | -544K | 3.25M | 24.15M | 1.67M | 6.9M | 288K | 1.8M | 12.33M | 1.41M | -11.97M | 5.32M | 6.64M | -4.52M |
| Working Capital Changes | 0 | -51.36M | -49.2M | 11.49M | 13.91M | -5.13M | -7.88M | -2.9M | 13.87M | 1.97M | 29.67M | -46.2M | 5.42M | -17.07M | -24.49M | 39.03M | -21.72M | 28.77M | -44.58M | 14.45M |
| Change in Receivables | 5.62M | -16.42M | -7.13M | 4.81M | -3.56M | 3.33M | 7.09M | -4.76M | -3.58M | -2.39M | -5.21M | 4.39M | 21.97M | -1.41M | -5.87M | -12.9M | 3.81M | -3.48M | 3.75M | -10.2M |
| Change in Inventory | 1.81M | -4.18M | -12.94M | 4.89M | 4.73M | 3.19M | 4.6M | 6.03M | 1.99M | 5.03M | 6.91M | -3.98M | -1.85M | -11.55M | -8.15M | 4.31M | -2.47M | -5.25M | -1.38M | -6.9M |
| Change in Payables | 49K | -491K | -21.53M | -6.49M | 3.94M | -418K | -11.83M | -12.79M | 10.02M | -269K | -6.09M | -19.38M | -10.55M | -6.5M | -24.42M | 41.24M | -29.48M | 33.91M | -10.05M | 4.33M |
| Cash from Investing | -19.22M | -51.31M | 48.71M | -30.61M | 37.32M | -12.64M | -77.01M | -48.59M | -51.62M | -65.98M | 34.63M | 60.3M | 239.78M | -48.77M | -82.23M | -15.68M | -69.99M | 76.13M | -5.7M | -80.89M |
| Capital Expenditures | 0 | -1.34M | -129K | -455K | -327K | -213K | -200K | -64K | -248K | 36K | -150K | -159K | -278K | 861K | -147K | 576K | -851K | -40K | -44K | 0 |
| CapEx % of Revenue | - | 0.63% | 0.07% | 0.27% | 0.22% | 0.12% | 0.11% | 0.04% | 0.17% | 0.02% | 0.1% | 0.12% | 0.18% | 0.51% | 0.08% | 0.34% | 0.56% | 0.03% | 0.03% | - |
| Acquisitions | 0 | -293.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 82.08M | 0 | 0 | -310.74M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 21K | -55.85M | -293.09M | 0 | 0 | 0 | 9K | 0 | 0 | 0 | 0 | 0 | 0 | -851K | -82.08M | 0 | 0 | 12.89M | 0 | -950K |
| Cash from Financing | 9.12M | 8.53M | 21.07M | 935K | -21.4M | 5.89M | 3.08M | 1.66M | 1.57M | 1.09M | -230K | -478.92M | 80.17M | 2.83M | 6.46M | 2.27M | -22.03M | -136.74M | 1.32M | 2.75M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -480.86M | 78.36M | 0 | 0 | 0 | 0 | -138.31M | 0 | 0 |
| Equity Issued (Net) | 0 | 8.56M | 23.74M | 3.28M | 2.04M | 6.88M | 3.46M | 1.66M | 2.91M | 3.08M | 740K | 2.52M | 2.26M | 2.83M | 6.46M | 2.27M | 866K | 1.57M | 524K | 2.75M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 9.12M | -31K | -2.67M | -2.34M | -23.44M | -987K | -387K | -1K | -1.34M | -1.99M | -970K | -575K | -445K | 0 | 0 | 0 | -22.9M | 0 | 800K | 0 |
| Net Change in Cash | 56.42M | -22.92M | 8.11M | 28.86M | 46.52M | 37.66M | -20.42M | -11.31M | -11.65M | -19.93M | 70.28M | -437.49M | 369.08M | -18.37M | -61.94M | 57.71M | -87.72M | -11.85M | -8.49M | -31.87M |
| Free Cash Flow | 66.52M | 19.43M | -61.79M | 58.08M | 30.27M | 44.19M | 53.32M | 35.56M | 38.15M | 44.99M | 35.73M | -19.03M | 48.85M | 28.43M | 13.69M | 71.69M | 3.45M | 48.72M | -4.15M | 46.27M |
| FCF Margin % | 32.03% | 9.19% | -32.17% | 35.1% | 20.21% | 25.38% | 30.35% | 21.13% | 26.56% | 27.38% | 23.22% | -14.04% | 31.77% | 16.99% | 7.72% | 42.16% | 2.26% | 30.63% | -2.8% | 32.74% |
| FCF Growth % | 119.75% | -56.02% | -215.89% | 63.33% | -20.66% | -1.78% | 49.25% | 286.83% | -21.89% | 58.29% | 160.88% | -126.55% | 1315.47% | -41.66% | 429.66% | 54.94% | -90.05% | 53.61% | -176.4% | -49.38% |
| FCF per Share | 1.15 | 0.34 | -1.09 | 1.03 | 0.54 | 0.78 | 0.95 | 0.64 | 0.69 | 0.82 | 0.65 | -0.35 | 0.78 | 0.46 | 0.25 | 1.17 | 0.06 | 0.89 | -0.08 | 0.85 |
| FCF Conversion (FCF/Net Income) | -29.01x | -4.84x | 1.37x | 2.60x | -2.59x | 2.90x | 1.39x | 1.79x | 309.69x | 38.26x | -2.25x | 22.71x | 2.90x | 1.08x | 7.91x | 9.04x | 0.17x | 19.97x | -0.19x | 1.95x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.95M | 0 | 0 | 1.26M | 0 | 1.26M | 629K | 629K | 0 |
| Taxes Paid | 0 | 0 | 3.08M | 12.42M | 274K | 12.91M | 19.58M | 20.43M | 336K | 9.55M | 6.62M | 20.23M | 203K | 1.64M | 6.01M | 0 | 478K | 79K | 4.42M | 20.39M |